AMINOHIPPURATE SODIUM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Aminohippurate Sodium, and what generic alternatives are available?
Aminohippurate Sodium is a drug marketed by Merck and is included in one NDA.
The generic ingredient in AMINOHIPPURATE SODIUM is aminohippurate sodium. Additional details are available on the aminohippurate sodium profile page.
Summary for AMINOHIPPURATE SODIUM
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 194 |
Clinical Trials: | 6 |
Patent Applications: | 1,072 |
Formulation / Manufacturing: | see details |
DailyMed Link: | AMINOHIPPURATE SODIUM at DailyMed |
Recent Clinical Trials for AMINOHIPPURATE SODIUM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
M.H.H. Kramer | Phase 4 |
AstraZeneca | Phase 4 |
Brigham and Women's Hospital | Phase 2 |
US Patents and Regulatory Information for AMINOHIPPURATE SODIUM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Merck | AMINOHIPPURATE SODIUM | aminohippurate sodium | INJECTABLE;INJECTION | 005619-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |